Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 2;36:100850. doi: 10.1016/j.ijcha.2021.100850

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 3 — Network meta-analysis of (a) stroke plus all-cause death events, (b) acute myocardial infarction events, and (c) stent thrombosis events for the therapeutic effect evaluation of antithrombotic drugs within 12 months after PCI. PCI, percutaneous coronary intervention; CI, confidence interval; 1 or TAT, warfarin + P2Y12 inhibitor + aspirin; 2 or XaD, Xa inhibitor + P2Y12 inhibitor; 3 or XaT, Xa inhibitor + P2Y12 inhibitor + aspirin; 4 or VKAD, VKA + P2Y12 inhibitor; 5 or IIaD110, IIa inhibitor 110 mg bid + P2Y12 inhibitor; 6 or IIaD150, IIa inhibitor 150 mg bid + P2Y12 inhibitor.

Fig. 3 — Network meta-analysis of (a) stroke plus all-cause death events, (b) acute myocardial infarction events, and (c) stent thrombosis events for the therapeutic effect evaluation of antithrombotic drugs within 12 months after PCI. PCI, percutaneous coronary intervention; CI, confidence interval; 1 or TAT, warfarin + P2Y12 inhibitor + aspirin; 2 or XaD, Xa inhibitor + P2Y12 inhibitor; 3 or XaT, Xa inhibitor + P2Y12 inhibitor + aspirin; 4 or VKAD, VKA + P2Y12 inhibitor; 5 or IIaD110, IIa inhibitor 110 mg bid + P2Y12 inhibitor; 6 or IIaD150, IIa inhibitor 150 mg bid + P2Y12 inhibitor.